MyFinsight
Home
About
Contact
beam: the income statement
Download
Download image
Comprehensive loss
-$111,948K
(-19.35%↓ Y/Y)
Unrealized gain (loss) on
marketable securities
$780K
(-72.81%↓ Y/Y)
Net loss
-$112,728K
(-16.61%↓ Y/Y)
Interest and other income
(expense), net
$10,903K
(-10.09%↓ Y/Y)
Change in fair value of
contingent consideration...
-$1,000K
Change in fair value of
non-controlling equity...
$4,937K
(339.20%↑ Y/Y)
Net loss before
income taxes
-$112,728K
(-16.61%↓ Y/Y)
Total other income
(expense)
$14,083K
(43.18%↑ Y/Y)
Change in fair value of
derivative liabilities
-$2,757K
(-1278.50%↓ Y/Y)
Loss from operations
-$126,811K
(-19.07%↓ Y/Y)
License and
collaboration revenue
$9,698K
(-32.03%↓ Y/Y)
Total operating
expenses
$136,509K
(13.03%↑ Y/Y)
General and
administrative
$26,740K
(0.85%↑ Y/Y)
Research and development
$109,769K
(16.46%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Beam Therapeutics Inc. (BEAM)
Beam Therapeutics Inc. (BEAM)